JOBST Arion Magnide, Each (Medium - Large - X-Large)

JOBST Arion Magnide, Each (Medium - Large - X-Large)

Marsoni

M251S

$90.66

Get it in 3 business days with 1 day shipping. Friday, May 29

JOBST Arion Magnide, Each (Medium - Large - X-Large)The application aid with a unique magnetic system to put on closed toe compression stockings. Thanks to its unique sliding properties and magnetic system, Arion Magnide provides an easy, safe, and simple solution to help put on smoothly medical compression stockings and tights with a closed toe. Arion Magnide reduces friction between the skin and the compression garment. This helps the stocking slide easily and smoothly over the skin. This contributes

Easy Shipping

Quick Dispatch:

Your JOBST Arion Magnide, Each (Medium - Large - X-Large) orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your JOBST Arion Magnide, Each (Medium - Large - X-Large) ships.

Need Help?
Questions about JOBST Arion Magnide, Each (Medium - Large - X-Large), sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for JOBST Arion Magnide, Each (Medium - Large - X-Large) in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Runs much larger than I expected. I am 5’4”& 136 pounds. Usually wear a medium or large in some knit tops. So I need to stitch the side seams in hopes it will fit better. I like the weight and softness of the fabric, but really disappointed in the too large armholes. Unwearable for me until I can sew new side seams.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on February 11, 2026